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Dr Baker. Other investigators have attempted to evaluate this
relationship, and in fact, Dr Mitchell previously found that higher
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Dr Eugene Zierler (Seattle, Wash). I noticed that in three of
the superior mesenteric artery (SMA) reinterventions, the angio-
graphic severity of restenosis was determined to be 50% or less,
resulting in an average SMA stenosis of 53% prior to reinterven-
tion. Since the average prestenting angiographic SMA stenosis was
79%, how do explain the need for reintervention with these rela-
tively modest stenoses?
Dr Aaron C. Baker. The need for intervention cannot be
made in a vacuum using imaging results primarily, and the clinical
context is essential in deciding to reintervene. These three patients
that had an in-stent restenosis of 50% or less also had concomitant
high-grade stenosis or occlusion of the celiac vessel. Thus, these
patients were less likely to tolerate mesenteric ischemia as a result of
in-stent restenosis or occlusion. In each of these three cases
though, the increased in-stent SMA peak systolic velocity (PSV)
seen on surveillance duplex ultrasound was a critical component to
the clinical decision making, and did lead to correct identification
of in-stent restenosis, but the final decision to reintervene was
made in combination with the overall clinical picture.
Dr Zierler. Second, when the SMA is evaluated by duplex
scanning, it is possible that the flow pattern could be influenced by
the status of the celiac artery and the intervening mesenteric
collateral pathways. This is analogous to the right and left extracra-
nial carotid systems that are connected to a variable extent by the
Circle of Willis. It is well recognized that when there is a unilateral
internal carotid artery stenosis and a contralateral internal carotid
occlusion, flow velocities may be increased on the patent side due
to compensatory collateral flow. This could also occur in the SMA
when the celiac artery is occluded. Of the reinterventions described
in this study, seven involved the SMA and only two involved the
celiac artery. Do you know the status of the celiac arteries in these
cases, and would it be possible to correlate the SMA velocities with
the status of the celiac artery?ressure gradients across the native SMAwere associated with higher-
rade stenosis of the celiac artery (CA). We have a great case example
f this exact phenomenon, which I showed in the figure depicting the
n-stent PSV changes that resulted in reintervention (Fig 4). This
atient had both CA and SMA stents and then had in-stent occlusion
f only the CA. What we can see is the SMA in-stent PSV increased
ith occlusion of the CA, but the SMA stent was completely patent.
fter successful restenting of the occludedCA stent, the in-stent SMA
SV subsequently decreased.While we can clearly see the interdepen-
ence between the CA and SMA in this case example, it was not
eadily apparent in other cases, and we did not specifically try to
orrelate the in-stent SMAvelocitieswith status of theCA.Aswewere
nable to correlate in-stent SMA and CA with angiographic stenosis,
would speculate that the correlation will be difficult to identify
iven our small number of patients in the reintervention cohort.
dditionally, we showed in the group of patients undergoing
nitial stenting of the SMA or CA that the CA PSV did not
ignificantly change from pre- to poststenting of either the CA
r the SMA. Similarly no significant change occurs between the
n-stent CA PSV pre- and postreintervention.
Dr Zierler. And finally, the flow pattern in the proximal SMA
an also be affected by a replaced right hepatic artery, which is
resent in 15% or more of the population. This is one recognized
ause of increased velocities in a normal native SMA. Do you recall
oting any replaced right hepatic arteries in your case series?
Dr Baker. A replaced right hepatic artery could have certainly
ontributed to increased in-stent SMA PSV, but we did not specifi-
ally evaluate its presence in our patients. Even if we were to investi-
ate this further, it is possible the stored images available for our
eview may not have captured the replaced right hepatic artery.
ertainly, any prospective study should consider the effect of a re-
laced right hepatic artery as well as evaluating the relationship be-
ween the CA and SMA, as we discussed with the previous question.INVITED COMMENTARYGustavo S. Oderich, MD, Rochester, Minn
Mesenteric stents have been plagued by high rates of restenosis
(20%-66%) and reintervention.1 Although most reinterventions are
indicated for chronic symptoms, a minority of patients can present
with acute stent thrombosis andbowel ischemia.1 In a recent survey ofesenteric ischemia, acute mesenteric ischemia was the fourth most
ommon cause of death, occurring in7%of patients after dismissal.2
herefore, patients treated by mesenteric stents should be followed
ith clinical examination and duplex ultrasound surveillance to detect
ecurrent symptoms and high-grade restenosis.
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November 20121372 OderichDuplex ultrasound has been widely accepted as a screening tool
to identify mesenteric stenosis. Currently, there is no accepted crite-
rion to detect in-stent restenosis. Prior studies have suggested that the
velocitymeasures used to diagnose native artery stenosis (peak systolic
velocity [PSV] 200 cm/s for celiac and 275 cm/s for superior
mesenteric artery [SMA]) overestimate the presence of restenosis after
stent placement.1,3,4 In this issue of the Journal, Baker and associates
confirm these observations and describe longitudinal changes in PSVs
on a cohort of patients treated by mesenteric stents for chronic
mesenteric ischemia.5 In their study, despite excellent technical result
by angiography, PSV remained higher than the accepted threshold
immediately after stent placement (335  143 cm/s) with modest
increase during the first year (389 95 cm/s), reaching an average of
505  74 cm/s at time of reintervention. These findings are nearly
identical to other reports (Table).
It is unlikely that a prospective study will be done to validate
duplex ultrasound criteria for stented mesenteric arteries. Cur-
rently, most reinterventions are done for recurrent symptoms and
not for elevated PSV in an asymptomatic patient. Because most
institutions treat small number of patients and therapeutic plan-
ning can be done with computed tomography angiography
(CTA)/magnetic resonance angiography (MRA), it is difficult to
justify angiography in an asymptomatic patient who does not need
reintervention. In the absence of such a study, recognizing the
limitations of retrospective reports, a few conclusions can be made
Table. Duplex mesenteric ultrasound peak systolic
velocity (PSV) measurements after stent placement
Author
PSV (cm/s)
1 month 12 months At reintervention
Baker et al5 335  138 389  138 505  74
Tallarita et al1 307  140 _ 440  81
AbuRahma et al4 220  71a 410  177b
Mitchell et al3 336  45 _
SMA, Superior mesenteric artery.
aMean PSV for 50% SMA stenosis.
bMean PSV for 50% SMA stenosis.on the basis of the observations reported by Baker and colleagues,
along with other recent reports:1) The native artery criteria should not be used to determine
in-stent restenosis;
2) There is no consensus on specific criteria to correlate with
degree of stenosis, although AbuRahma and colleagues have
recently suggested cut points for 50% (275 cm/s for celiac
and 325 cm/s for SMA) and 70% in-stent restenosis (363
cm/s for celiac and 412 cm/s for SMA); and
3) A reintervention should not be indicated on the basis of PSV
criteria alone.
Most frequently, reinterventions are needed for recurrent symp-
oms, although we have also treated a minority of patients who
rogress to high PSVs (500 cm/s) with dampened waveforms.
The author’s preference is to obtain a duplex ultrasound
mmediately after placement of a mesenteric stent, both to confirm
reduction in PSV and to provide a benchmark for future com-
arison. If the PSV remains exceedingly high immediately after
tent placement, the angiographic study should be carefully re-
iewed to identify any missed lesion, which may be subtle. One
hould recognize limitations of angiography studies done in a
ingle lateral view, as residual stenosis may be noted on anterior–
osterior view. Finally, mesenteric duplex ultrasound study should
e done with careful attention to the technique as espoused in the
tudy by Baker, and colleagues.
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